Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.23 - $7.82 $136,063 - $203,445
-26,016 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.29 - $10.97 $189,656 - $285,395
26,016 New
26,016 $195,000
Q1 2021

May 14, 2021

SELL
$10.88 - $17.05 $127,546 - $199,877
-11,723 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$9.23 - $18.18 $108,203 - $213,124
11,723 New
11,723 $183,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.